Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01015807 · ClinicalTrials.gov registry record · NA
Transversus Abdominis Plane (TAP) Block for Cesarean Section
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01015807 is a NA study that has completed, run by University of Washington. The registered enrollment target is 90 participants.
The verdict
NCT01015807, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a transversus abdominis plane (TAP) block with Clonidine added to the injectate (Clo-TAP) performed approximately 2hrs after the cesarean section (CS) will decrease the amount of postoperative hyperalgesia and ultimately reduce post-CS chronic pain.
Interventions
- DRUG Bupivacaine
- DRUG Clonidine
- DRUG Bupivacaine Placebo
- DRUG Clonidine Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01015807
The ClinicalTrials.gov registry entry for NCT01015807 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Bupivacaine is the first listed.
NCT01015807 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01015807 about?
NCT01015807 is a clinical study titled "Transversus Abdominis Plane (TAP) Block for Cesarean Section". The purpose of this study is to determine whether a transversus abdominis plane (TAP) block with Clonidine added to the injectate (Clo-TAP) performed approximately 2hrs after the cesarean section (CS) will decrease the amount of postoperative hyperalgesia and ultimately reduce post-CS chronic pain.
What is the current status of trial NCT01015807?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2009-11. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01015807?
The interventions under investigation include: Bupivacaine (DRUG), Clonidine (DRUG), Bupivacaine Placebo (DRUG), Clonidine Placebo (DRUG).
Who is sponsoring clinical trial NCT01015807?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.